Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Lomas

Showing results (191-200 of 282) with videos related to

Pageof 29
Sort By:
ERJ Open Research|March 15, 2021
Prognostic value of clinically important deterioration in COPD: IMPACT trial analysisMeiLan K Han, Gerard J Criner, Mark T Dransfield, et al.
The European Respiratory Journal|September 7, 2019
Misinterpretation of time-to-first event curves can lead to inappropriate treatmentBenjamin Hartley, Gerard J Criner, Mark T Dransfield, et al.
Respiratory Research|February 2, 2023
X chromosome associations with chronic obstructive pulmonary disease and related phenotypes: an X chromosome-wide association studyLystra P Hayden, Brian D Hobbs, Robert Busch, et al.
Advances in Therapy|July 11, 2020
Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT StudyMaggie Tabberer, C Elaine Jones, Sally Kilbride, et al.
The European Respiratory Journal|June 15, 2013
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohortAlvar Agusti, Lisa D Edwards, Bartolomé Celli, et al.
Science Advances|October 22, 2020
The structural basis for Z α<sub>1</sub>-antitrypsin polymerization in the liverSarah V Faull, Emma L K Elliston, Bibek Gooptu, et al.
The Biochemical Journal|July 14, 2016
An antibody that prevents serpin polymerisation acts by inducing a novel allosteric behaviourNeda Motamedi-Shad, Alistair M Jagger, Maximilian Liedtke, et al.
The International Journal of Biochemistry & Cell Biology|December 3, 2014
Characterising the association of latency with α(1)-antitrypsin polymerisation using a novel monoclonal antibodyLu Tan, Juan Perez, Marianna Mela, et al.
COPD|May 17, 2014
Evaluating the role of inflammation in chronic airways disease: the ERICA studyDivya Mohan, Nichola S Gale, Carmel M McEniery, et al.
Respiratory Research|June 7, 2020
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trialNicola C Day, Subramanya Kumar, Gerard Criner, et al.
Pageof 29

Showing results (191-200 of 282) with videos related to

Sort By:
Pageof 29
ERJ Open Research|March 15, 2021
Prognostic value of clinically important deterioration in COPD: IMPACT trial analysisMeiLan K Han, Gerard J Criner, Mark T Dransfield, et al.
The European Respiratory Journal|September 7, 2019
Misinterpretation of time-to-first event curves can lead to inappropriate treatmentBenjamin Hartley, Gerard J Criner, Mark T Dransfield, et al.
Respiratory Research|February 2, 2023
X chromosome associations with chronic obstructive pulmonary disease and related phenotypes: an X chromosome-wide association studyLystra P Hayden, Brian D Hobbs, Robert Busch, et al.
Advances in Therapy|July 11, 2020
Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT StudyMaggie Tabberer, C Elaine Jones, Sally Kilbride, et al.
The European Respiratory Journal|June 15, 2013
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohortAlvar Agusti, Lisa D Edwards, Bartolomé Celli, et al.
Science Advances|October 22, 2020
The structural basis for Z α<sub>1</sub>-antitrypsin polymerization in the liverSarah V Faull, Emma L K Elliston, Bibek Gooptu, et al.
The Biochemical Journal|July 14, 2016
An antibody that prevents serpin polymerisation acts by inducing a novel allosteric behaviourNeda Motamedi-Shad, Alistair M Jagger, Maximilian Liedtke, et al.
The International Journal of Biochemistry & Cell Biology|December 3, 2014
Characterising the association of latency with α(1)-antitrypsin polymerisation using a novel monoclonal antibodyLu Tan, Juan Perez, Marianna Mela, et al.
COPD|May 17, 2014
Evaluating the role of inflammation in chronic airways disease: the ERICA studyDivya Mohan, Nichola S Gale, Carmel M McEniery, et al.
Respiratory Research|June 7, 2020
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trialNicola C Day, Subramanya Kumar, Gerard Criner, et al.
Pageof 29